Category:

Medications for the Masses? Pharmacogenomics is an Important Public Health Issue

Adverse drug events are a serious public health problem. Consider the following facts: an estimated 82% of American adults take at least one medication and 29% take five or more; 700,000 emergency department visits and 120,000 hospitalizations are due to adverse drug events annually; $3.5 billion is spent on extra medical costs of adverse drug Read More >

July 21, 2011 by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention3 Comments

genomics, pharmacogenomics

genetics, genomics, pharmacogenomics, public health

What are the Priorities for Public Health Genomics 2012-2017?

Since 1997, the Office of Public Health Genomics (OPHG) at the Centers for Disease Control and Prevention (CDC) has worked to integrate genomics into public health research, policy, and programs. Our driving force is to improve interventions designed to prevent and control the country’s leading chronic, infectious, environmental, and occupational diseases. OPHG’s efforts focus on conducting Read More >

July 7, 2011 by Muin J Khoury, Director, Office of Public Health Genomics, Centers for Disease Control and Prevention1 Comment

genomics

genetics, genomics, public health